Transthyretin-related (attr) familial amyloid cardiomyopathy Clinical Trials
Conditions / Transthyretin-related (attr) familial amyloid cardiomyopathy
Delta Trials indexes 4 clinical trials for Transthyretin-related (attr) familial amyloid cardiomyopathy in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 2 trials have reached completion. This research takes place spanning 66 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
4
Total Trials
2
Recruiting
2
Completed
0
Other Active
0
Terminated since 2020
66
Study Locations
Browse by location (66 total)
- Auckland, New Zealand 2 trialsAll trials in Auckland, New Zealand
- Umeå, Sweden 2 trialsAll trials in Umeå, Sweden
- London, United Kingdom 2 trialsAll trials in London, United Kingdom
- Paris, France 2 trialsAll trials in Paris, France
- Paris, France 2 trialsAll trials in Paris, France
- Haar, Germany 1 trialAll trials in Haar, Germany
- Zug, Switzerland 1 trialAll trials in Zug, Switzerland
- Teupitz, Germany 1 trialAll trials in Teupitz, Germany
- Mainz, Germany 1 trialAll trials in Mainz, Germany
- All trials in Bad Neustadt an der Saale, Germany
- Wermsdorf, Germany 1 trialAll trials in Wermsdorf, Germany
- Halle, Germany 1 trialAll trials in Halle, Germany
- Fulda, Germany 1 trialAll trials in Fulda, Germany
- Gießen, Germany 1 trialAll trials in Gießen, Germany
- All trials in Buchholz in der Nordheide, Germany
- Friedberg, Germany 1 trialAll trials in Friedberg, Germany
- Celle, Germany 1 trialAll trials in Celle, Germany
- Perleberg, Germany 1 trialAll trials in Perleberg, Germany
- Leipzig, Germany 1 trialAll trials in Leipzig, Germany
- Hamburg, Germany 1 trialAll trials in Hamburg, Germany